CagriSema, considered a successor to Wegovy, is Novo Nordisk’s most likely route of gaining GLP-1RA market share back from ...

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

Indian benchmark equity indices reduced their initial gains and were in negative territory on Thursday, influenced by ...

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks ...

We recently published a list of 10 Firms Buck Market Slump on Impressive Earnings, New Deals. In this article, we are going ...

US imports surged to a record high in December, official figures showed today as Donald Trump’s threat of tariffs triggered a ...

President Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

He also sardonically targeted co-host David Faber and said “Look I’m sure that when they discovered the cotton gin, and ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

Indian markets closed lower as gains in financial and oil & gas stocks were offset by consumer sector declines. Investors ...